Works by Galbraith, Matthew D.

Results: 18
    1
    2
    3

    Seroconversion stages COVID19 into distinct pathophysiological states.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.65508
    By:
    • Galbraith, Matthew D.;
    • Kinning, Kohl T.;
    • Sullivan, Kelly D.;
    • Baxter, Ryan;
    • Araya, Paula;
    • Jordan, Kimberly R.;
    • Russell, Seth;
    • Smith, Keith P.;
    • Granrath, Ross E.;
    • Shaw, Jessica R.;
    • Dzieciatkowska, Monika;
    • Ghosh, Tusharkanti;
    • Monte, Andrew A.;
    • D'Alessandro, Angelo;
    • Hansen, Kirk C.;
    • Benett, Tellen D.;
    • Hsieh, Elena W. Y.;
    • Espinosa, Joaquín M.
    Publication type:
    Article
    4

    Plasma biomarkers of neurodegeneration in the brain (UCH‐L1 and NfL) become exponentially higher with age from early childhood, and treatment of Alzheimer's disease participants with granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) lowers age‐associated levels of plasma UCH‐L1 by six decades

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092726
    By:
    • Sillau, Stefan H;
    • Coughlan, Christina M;
    • Ahmed, Md. Mahiuddin;
    • Nair, Kavita V;
    • Araya, Paula;
    • Galbraith, Matthew D.;
    • Bettcher, Brianne M;
    • Espinosa, Joaquin M.;
    • Chial, Heidi J;
    • Epperson, Neill;
    • Boyd, Timothy D.;
    • Potter, Huntington
    Publication type:
    Article
    5
    6

    JAK inhibition decreases the autoimmune burden in Down syndrome.

    Published in:
    eLife, 2024, p. 1, doi. 10.7554/eLife.99323
    By:
    • Rachubinski, Angela L.;
    • Wallace, Elizabeth;
    • Gurnee, Emily;
    • Enriquez-Estrada, Belinda A.;
    • Worek, Kayleigh R.;
    • Smith, Keith P.;
    • Araya, Paula;
    • Waugh, Katherine A.;
    • Granrath, Ross E.;
    • Britton, Eleanor;
    • Lyford, Hannah R.;
    • Donovan, Micah G.;
    • Eduthan, Neetha Paul;
    • Hill, Amanda A.;
    • Martin, Barry;
    • Sullivan, Kelly D.;
    • Patel, Lina;
    • Fidler, Deborah J.;
    • Galbraith, Matthew D.;
    • Dunnick, Cory A.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Trisomy 21 consistently activates the interferon response.

    Published in:
    eLife, 2016, p. 1, doi. 10.7554/eLife.16220
    By:
    • Sullivan, Kelly D.;
    • Lewis, Hannah C.;
    • Hill, Amanda A.;
    • Pandey, Ahwan;
    • Jackson, Leisa P.;
    • Cabral, Joseph M.;
    • Smith, Keith P.;
    • Liggett, L. Alexander;
    • Gomez, Eliana B.;
    • Galbraith, Matthew D.;
    • DeGregori, James;
    • Espinosa, Joaquín M.
    Publication type:
    Article
    15

    EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 12, p. 2287, doi. 10.1093/neuonc/noad128
    By:
    • Wolin, Arthur R;
    • Vincent, Melanie Y;
    • Hotz, Taylor;
    • Purdy, Stephen C;
    • Rosenbaum, Sheera R;
    • Hughes, Connor J;
    • Hsu, Jessica Y;
    • Oliphant, Michael U J;
    • Armstrong, Brock;
    • Wessells, Veronica;
    • Varella-Garcia, Marileila;
    • Galbraith, Matthew D;
    • Pierce, Angela;
    • Wang, Dong;
    • Venkataraman, Sujatha;
    • Danis, Etienne;
    • Veo, Bethany;
    • Serkova, Natalie;
    • Espinosa, Joaquin M;
    • Gustafson, Daniel L
    Publication type:
    Article
    16
    17
    18